Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Pharm Pharmacol ; 63(10): 1309-19, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21899547

RESUMEN

OBJECTIVES: Acteoside is a phenylpropanoid glycoside extracted from the leaves of Rehmannia glutinosa that displays various biological activities. In this study, we tested the effects of acteoside on tyrosinase activity and melanin biosynthesis in B16F10 melanoma cells. We also explored molecular mechanisms for the inhibition of melanogenesis observed, focusing on the signalling pathway of extracellular signal-regulated kinase (ERK). METHODS: The effects of acteoside were determined using several cell-free assay systems and B16F10 melanoma cells for melanin content and tyrosinase activity. To investigate effects on melanogenic regulatory factors we performed reverse transcription polymerase chain reaction, cAMP assay and Western blot analyses. KEY FINDINGS: Acteoside showed an inhibitory effect on tyrosinase activity and melanin synthesis in both cell-free assay systems and cultured B16F10 melanoma cells. Acteoside decreased levels of tyrosinase, tyrosinase-related protein-1 (TRP-1) and microphthalmia-associated transcription factor (MITF) proteins, whereas it increased ERK phosphorylation. A specific ERK inhibitor, PD98059, abolished the acteoside-induced down-regulation of MITF, tyrosinase and TRP-1 proteins. The ERK inhibitor increased tyrosinase activity and melanin production and reversed the acteoside-induced decrease in tyrosinase activity and melanin content. In addition, acteoside suppressed melanogenesis induced by α-melanocyte-stimulating hormone and showed UV-absorbing effects. CONCLUSIONS: Acteoside decreased tyrosinase activity and melanin biosynthesis in B16F10 cells by activating ERK signalling, which down-regulated MITF, tyrosinase and TRP-1 production.


Asunto(s)
Inhibidores Enzimáticos/farmacología , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Glucósidos/farmacología , Melaninas/biosíntesis , Monofenol Monooxigenasa/antagonistas & inhibidores , Fenoles/farmacología , Extractos Vegetales/farmacología , Rehmannia/química , Línea Celular Tumoral , Regulación hacia Abajo , Activación Enzimática/efectos de los fármacos , Flavonoides/farmacología , Humanos , Melanoma Experimental , Factor de Transcripción Asociado a Microftalmía/metabolismo , Oxidorreductasas/metabolismo , Fosforilación , Hojas de la Planta , Transducción de Señal , alfa-MSH/metabolismo
2.
Redox Rep ; 10(6): 311-8, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16438803

RESUMEN

Acteoside extracted from the leaves of Rehmannia glutinosa was examined to determine the mechanism(s) of its antioxidant properties. The deoxyribose assay system showed that acteoside has a high redox potential as electron donor, which generates hydroxyl radicals in an Fe3+-dependent manner similar to ascorbic acid. However, the antioxidant properties of acteoside differ from those of ascorbic acid in that the superoxide anion-mediated reduction of nitroblue tetrazolium was actively inhibited by acteoside but not by ascorbic acid. Acteoside protected cells against glucose oxidase-mediated cytotoxicity and apoptosis in a dose-dependent manner. In addition, acteoside had immune stimulating effects, as shown by the acteoside-mediated increase in the level of DNA synthesis, viability, and cytokine secretion in mouse splenocytes. Moreover, acteoside inhibited the gelatinolytic activity of MMP proteins in a dose-dependent manner. Considering these results and the fact that acteoside is a water-soluble natural product, acteoside might have potential as a preventative treatment for oxidative stress-mediated diseases and have possibilities in the cosmetic industry.


Asunto(s)
Antioxidantes/farmacología , Paraquat/farmacología , Hojas de la Planta/efectos de los fármacos , Rehmannia/metabolismo , Animales , Antioxidantes/metabolismo , Ácido Ascórbico/química , Desoxirribosa , Herbicidas/farmacología , Ratones , Células 3T3 NIH , Nitroazul de Tetrazolio/farmacología , Oxidación-Reducción , Estrés Oxidativo , Extractos Vegetales/metabolismo , Superóxidos/química
3.
Mol Cells ; 16(1): 34-9, 2003 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-14503842

RESUMEN

Rehmannia glutinosa is a medicinal herb that is tolerant to the non-selective herbicide paraquat. Acteoside, a phenolic compound present in the plant, has been shown to inhibit paraquat. To understand regulation of the phenylpropanoid pathway that produces the acteoside moiety, we isolated a phenylalanine ammonia-lyase (PAL) cDNA clone (RgPAL1) and used it to examine PAL expression. The deduced 712 amino acid sequence of the open reading frame contains the conserved active site and potential phosphorylation sites of other plant PALs. RgPAL1 mRNA was detected in the leaves, flowers and roots of healthy plants, and the level of the mRNA was higher in leaves than in flowers and roots. RgPAL1 mRNA was induced in leaves by paraquat, H2O2, UV light, wounding, yeast extract, jasmonic acid and ethephon. The transcript level and enzyme activity increased gradually from 6 to 24 h after exposure to paraquat or jasmonic acid. Induction of RgPAL1 by paraquat and stress-related phytohormones suggests that it is involved in the regulation of the phenylpropanoid pathway under oxidative stress.


Asunto(s)
Regulación de la Expresión Génica de las Plantas , Herbicidas/metabolismo , Paraquat/metabolismo , Fenilanina Amoníaco-Liasa/genética , Fenilanina Amoníaco-Liasa/metabolismo , Reguladores del Crecimiento de las Plantas/metabolismo , Rehmannia/enzimología , Secuencia de Aminoácidos , Ciclopentanos/metabolismo , Datos de Secuencia Molecular , Estrés Oxidativo , Oxilipinas , Fenilanina Amoníaco-Liasa/clasificación , Filogenia , ARN Mensajero/metabolismo , Rehmannia/genética , Alineación de Secuencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...